Astrana Health, Inc.
NASDAQ Capital MarketTotal Valuation
Astrana Health, Inc. carries a market capitalization of 1.91B, placing it among publicly traded companies globally. Its enterprise value stands at 2.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.91B |
| Enterprise Value | 2.27B |
Share Statistics
Astrana Health, Inc. currently has 48.95M shares outstanding.
| Shares Outstanding | 48.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Astrana Health, Inc. trades at a trailing price-to-earnings ratio of 102.88.
| PE Ratio | 102.88 |
| PS Ratio | 0.75 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 25.42 |
| P/OCF Ratio | 28.49 |
Enterprise Valuation
On an enterprise value basis, Astrana Health, Inc. trades at an EV/EBITDA multiple of 19.99 and an EV/FCF ratio of 19.39. The EV/Sales ratio of 0.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.35 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.79 |
| EV / EBITDA | 19.99 |
| EV / EBIT | 34.35 |
| EV / FCF | 19.39 |
Financial Position
Astrana Health, Inc. maintains a current ratio of 4.15, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 573.56, indicating elevated leverage, while an interest coverage ratio of 2.21 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.15 |
| Quick Ratio | 4.04 |
| Debt / Equity | 573.56 |
| Debt / EBITDA | N/A |
| Interest Coverage | 2.21 |
Financial Efficiency
Astrana Health, Inc. posts a return on equity of 5.44 and a return on invested capital of 8.48.
| Return on Equity (ROE) | 5.44 |
| Return on Assets (ROA) | 2.89 |
| Return on Invested Capital (ROIC) | 8.48 |
| Return on Capital Employed (ROCE) | 10.81 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Astrana Health, Inc. has paid 12.12M in income taxes, reflecting an effective tax rate of 36.84.
| Income Tax | 12.12M |
| Effective Tax Rate | 36.84 |
Stock Price Statistics
Astrana Health, Inc.'s stock has gained approximately 24.82154% over the past 52 weeks. The 50-day moving average sits at 40.96, while the 200-day moving average is 31.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.82154% |
| 50-Day Moving Average | 40.96 |
| 200-Day Moving Average | 31.28 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Astrana Health, Inc. generated 2.87B in revenue and converted that into 20.81M in net income, yielding earnings per share of 0.45. EBITDA reached 113.61M, while operating income came in at 66.13M.
| Revenue | 2.87B |
| Gross Profit | 297.98M |
| Operating Income | 66.13M |
| Pretax Income | 32.89M |
| Net Income | 20.81M |
| EBITDA | 113.61M |
| EBIT | 66.13M |
| Earnings Per Share (EPS) | 0.45 |
Cash Flow
Astrana Health, Inc. produced 75.13M in operating cash flow over the past twelve months. After subtracting -9.62M in capital expenditures, free cash flow totaled 65.51M - equivalent to 1.42 per share.
| Operating Cash Flow | 75.13M |
| Capital Expenditures | -9.62M |
| Free Cash Flow | 65.51M |
| FCF Per Share | 1.42 |
Margins
Astrana Health, Inc. operates with a gross margin of 10.38, reflecting its pricing power and cost economics. The operating margin of 2.30 and net profit margin of 0.72 provide insight into operational efficiency.
| Gross Margin | 10.38 |
| Operating Margin | 2.30 |
| Pretax Margin | 1.15 |
| Profit Margin | 0.72 |
| EBITDA Margin | 3.96 |
Dividends & Yields
The company's payout ratio of 8.47 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.04 |
| Dividend Yield | N/A |
| Payout Ratio | 8.47 |
| Shareholder Yield | -26.69 |
| FCF Yield | 3.93 |
Stock Splits
Astrana Health, Inc.'s most recent stock split took place on April 27, 2015 with a 10:1 split ratio.
| Last Split Date | 4/27/2015 |
| Split Ratio | 10:1 |
Scores
Astrana Health, Inc. posts an Altman Z-Score of 12.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.44 |